Today: 10 April 2026
Scottish village’s last bar goes on the market as Hillside Hotel near Montrose seeks buyer
8 January 2026
1 min read

Scottish village’s last bar goes on the market as Hillside Hotel near Montrose seeks buyer

MONTROSE, Scotland, January 8, 2026, 09:22 (GMT)

  • Hillside Hotel in Hillside, near Montrose, is for sale at offers over £280,000, according to a property listing
  • The Courier reported the owner is selling after 13 years, putting the village’s final bar and hotel in play
  • Scotland’s blood service said several key blood types sat below its six-day stock target on Thursday

The Hillside Hotel in the Angus village of Hillside, near Montrose, has been put up for sale for offers in excess of £280,000, a property listing showed. The marketing describes a recently refurbished hotel and public bar with eight en-suite letting rooms and a car park. PropList

The sale matters in a place like Hillside because there is not much slack. The Courier reported on Wednesday that owner Catherine Braes is selling up what it called the village’s final bar and hotel after 13 years. The Courier

The hotel trades as Hillside Hotel & Restaurant and bills itself as a small family-run business about three miles outside Montrose. Its website says it has eight en-suite rooms, a restaurant, and a dog-friendly bar, with on-site parking. Hillside Hotel

Agents are also pitching it as a “development” opportunity, language that in practice can mean anything from a straight handover to a change of use — if planners agree. The listing says alternative uses would be “subject to consent,” a shorthand way of saying planning permission is likely needed.

The uncertainty comes as Scotland’s blood service flagged tight stocks across several blood groups on Thursday. Scotblood, the Scottish National Blood Transfusion Service site, put O-negative at four days of stock left, with O-positive and A-positive also at four days — below its six-day target. Scotblood

The service says blood demand can swing and supplies cannot simply be stored up, because blood has a short shelf life. It updates the stock figures online each weekday.

In Montrose, RNLI volunteers tried to widen the donor base earlier this week, using a training night to donate at Montrose Town Hall. A crew member, Jen Crews, said “blood stock levels can be really low at times,” while Scottish National Blood Transfusion Service officer Gwen Fenton said active donors have “fallen from around 3% of the population to under 2%.” RNLI

But none of this is guaranteed to land cleanly. The hotel sale could drag on or end with a buyer repurposing the building, leaving the village without a bar; blood stocks can also slip quickly if bad weather or illness keeps donors away and hospitals stay busy.

Stock Market Today

  • Is Welltower (WELL) Overvalued After Five Years of Strong Gains?
    April 10, 2026, 1:33 AM EDT. Welltower (WELL), a leading health care REIT focusing on senior housing and medical properties, has surged 207.6% over five years. Despite gains, it returned 2.0% in the past week and is up 10.4% year to date. The stock currently trades around $206.34, slightly above its intrinsic value of $197.50 estimated via a Discounted Cash Flow (DCF) model using adjusted funds from operations, a key cash flow metric for REITs. This puts WELL about 4.5% overvalued, a modest premium that suggests the market price closely reflects expected future cash flows. However, Simply Wall St's valuation system scores WELL 0 out of 6, indicating investors should carefully weigh risks amid its steady growth projections through 2035.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 1:41 AM EDT Is Welltower (WELL) Overvalued After Five Years of Strong Gains? April 10, 2026, 1:33 AM EDT. Welltower (WELL), a leading health care REIT focusing on senior housing and medical properties, has surged 207.6% over five years. Despite gains, it returned 2.0% in the past week and is up 10.4% year to date. The stock currently trades around $206.34, slightly above its intrinsic value of $197.50 estimated via a Discounted Cash Flow (DCF) model using adjusted funds from operations, a key cash flow metric for REITs.
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
IAG stock edges up as Bernstein lifts target and Morgan Stanley flags cash returns
Previous Story

IAG stock edges up as Bernstein lifts target and Morgan Stanley flags cash returns

Jefferies lifts Barclays, Lloyds and NatWest price targets as UK bank rally rolls into 2026
Next Story

Jefferies lifts Barclays, Lloyds and NatWest price targets as UK bank rally rolls into 2026

Go toTop